


Sagesse Bio
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Sagesse Bio
Jon Meneese
President and Chief Executive Officer
Sagesse Bio Email Formats
Sagesse Bio uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@sagessebio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@sagessebio.com | 100% |
About Sagesse Bio
Sagesse Bio is an early stage pharmaceutical company utilizing RNAi technology to accelerate the clinical development of novel solutions to destroy or remodel undesirable pockets of fat. The company's lead compound, SGY-101, is IND-enabled and currently in Phase II clinical trials for other indications. Sagesse Bio will promptly begin clinical evaluation of SGY-101 with comprehensive scientific and technical support from Sirnaomics which specializes in the development of RNAi technology. Initial indications of interest include body contouring and fat reduction. The strategic goal of Sagesse Bio is to become the leading provider of therapeutic solutions for targeted fat reduction in both medical dermatology and aesthetic medicine.
Sagesse Bio revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Sagesse Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Sagesse Bio has never raised funding before.
Sagesse Bio Tech Stack
Discover the technologies and tools that power Sagesse Bio's digital infrastructure, from frameworks to analytics platforms.
Hosting
CMS
Miscellaneous
Security
JavaScript frameworks
JavaScript frameworks
Miscellaneous
Frequently asked questions
4.8
40,000 users



